CN
CNTMF.US Cansortium Inc
- Market cap
- USD 10.2M
- P/E
- -
- P/B
- 8.65x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is CNTMF.US undervalued?
Graham numberThe Graham number of Cansortium Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cansortium Inc fundamental analysis
No fundamental analysis for Cansortium Inc yet.
Cansortium Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cansortium Inc
FLUENT Corp., through its subsidiaries, cultivates, manufactures, processes, distributes, and sells medical cannabis products for medical and adult-use in the United States. Its medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles. The company also sells various third-party branded medical cannabis products, as well as other accessories. It offers its products under the Bag-O, FLUENT…
Full company profileCansortium Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cansortium Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | 8.06M | 28.5M | 52.4M | 65.4M | 87.7M | 97.3M | 87.4M | 86.7M | 70.0M |
| Gross Profit | - | -7.00K | 2.87M | 18.1M | 29.9M | 35.8M | 37.0M | 47.5M | 48.5M | 28.1M | 19.7M |
| Operating Income | -608K | -8.30M | -20.3M | -30.9M | -8.42M | -643K | 2.78M | 9.31M | 3.81M | -15.2M | -20.6M |
| EBITDA | - | - | 5.34M | -25.4M | -8.36M | 11.7M | 2.86M | 23.9M | -1.22M | -26.3M | -2.41M |
| Net Income | -2.06M | -10.1M | -327K | -65.3M | -36.6M | -19.0M | -37.4M | -22.8M | -40.4M | -72.5M | -52.1M |
| EPS | - | - | 0.00 | -0.65 | -0.30 | -0.08 | -0.14 | -0.08 | -0.06 | -0.11 | -0.08 |
| Balance Sheet | |||||||||||
| Total Assets | 6.07M | 18.1M | 140M | 167M | 155M | 182M | 178M | 178M | 207M | 149M | 134M |
| Total Liabilities | 256K | 6.32M | 74.8M | 120M | 127M | 120M | 150M | 169M | 216M | 230M | 240M |
| Shareholders' Equity | 5.82M | 11.8M | 65.7M | 47.2M | 27.8M | 62.6M | 27.6M | 8.59M | -8.98M | -81.0M | -107M |
| Cash & Short-term Investments | 1.32M | 3.03M | 2.03M | 2.52M | 3.39M | 9.02M | 8.36M | 10.5M | 40.1M | 4.41M | 2.52M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -536K | -5.06M | -12.0M | -22.7M | 6.67M | -5.03M | 19.1M | 18.5M | 1.77M | -588K | -2.35M |
| Capital Expenditure | 355K | 3.72M | 9.53M | 13.8M | 5.19M | 21.1M | 6.80M | 6.34M | 17.5M | 14.4M | 3.05M |
| Free Cash Flow | - | - | -21.8M | -36.8M | 2.90M | -26.4M | 12.3M | 12.1M | -15.7M | -15.0M | -5.41M |
| Ratios | |||||||||||
| ROE | -35.5% | -86.0% | -0.5% | -138.5% | -131.6% | -30.4% | -135.8% | -265.0% | - | - | - |
| ROA | -34.0% | -56.0% | -0.2% | -39.1% | -23.7% | -10.4% | -21.0% | -12.8% | -19.5% | -48.8% | -39.0% |
| Net Profit Margin | - | - | -4.1% | -229.1% | -69.9% | -29.1% | -42.7% | -23.4% | -46.2% | -83.6% | -74.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Cansortium Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | USD 600K | 0.01 | - |
| 2017 | USD 600K | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Cansortium Inc
- Insiders 36.89%
- Institutions 1.85%
- Public & others 61.26%
- Shares outstanding 613M
- Free float 385M
Cansortium Inc company profile
- Company name
- Cansortium Inc
- Ticker
- CNTMF.US
- ISIN
- CA13809L1094
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 826
- Fiscal year end
- December
- Address
- 5540 Executive Drive, Tampa, FL, United States, 33609
- Phone
- 833 735 8368
- Website
- investors.getfluent.com
About Cansortium Inc
FLUENT Corp., through its subsidiaries, cultivates, manufactures, processes, distributes, and sells medical cannabis products for medical and adult-use in the United States. Its medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles. The company also sells various third-party branded medical cannabis products, as well as other accessories. It offers its products under the Bag-O, FLUENT, Hyer Kind, Knack, MOODS, and Wandr brands. The company was formerly known as Cansortium Inc. and changed its name to FLUENT Corp. in February 2025. FLUENT Corp. was founded in 2015 and is headquartered in Tampa, Florida. As of November 9, 2026, FLUENT Corp. operates as a subsidiary of Vireo Growth Inc.
Cansortium Inc management
6- Mr. Matthew MundyInterim CEO & Chief Legal Officer
- Ms. Patricia FonsecaCFO & Corporate Secretary
- Mr. Victor BindiChief Operating Officer
- Mr. William M. SmithExecutive Chairman
- Dr. Jennifer McCafferty-FernandezChief Science Officer
- Mr. Jeffrey ReathConsultant